JPS5959632A
(ja)
*
|
1982-09-28 |
1984-04-05 |
Teikoku Chem Ind Corp Ltd |
徐放性組成物
|
US4713245A
(en)
*
|
1984-06-04 |
1987-12-15 |
Mitsui Toatsu Chemicals, Incorporated |
Granule containing physiologically-active substance, method for preparing same and use thereof
|
JPS6150912A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Shionogi & Co Ltd |
リポソ−ム製剤の製造法
|
US4755387A
(en)
*
|
1985-03-21 |
1988-07-05 |
The Procter & Gamble Company |
Therapeutic particles
|
FR2581541B1
(fr)
*
|
1985-05-09 |
1988-05-20 |
Rhone Poulenc Sante |
Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
|
US4820523A
(en)
*
|
1986-04-15 |
1989-04-11 |
Warner-Lambert Company |
Pharmaceutical composition
|
US4837381A
(en)
*
|
1986-08-11 |
1989-06-06 |
American Cyanamid Company |
Compositions for parenteral administration and their use
|
US4822619A
(en)
*
|
1987-02-18 |
1989-04-18 |
Ionor, Inc. |
Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
|
JP2668880B2
(ja)
*
|
1987-06-23 |
1997-10-27 |
日本油脂株式会社 |
被覆アミノ酸類の製造方法
|
DE3737741A1
(de)
*
|
1987-11-06 |
1989-05-18 |
Goedecke Ag |
Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
|
JP2681373B2
(ja)
*
|
1988-07-18 |
1997-11-26 |
塩野義製薬株式会社 |
徐放性製剤の製造法
|
EP0418596A3
(en)
*
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
US5213810A
(en)
*
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
IE61651B1
(en)
*
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
US5134016A
(en)
*
|
1990-10-31 |
1992-07-28 |
E. I. Du Pont De Nemours And Company |
Fiber reinforced porous sheets
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
DK0641195T3
(da)
*
|
1992-05-22 |
1996-08-05 |
Goedecke Ag |
Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
MX9707585A
(es)
*
|
1995-04-03 |
1997-12-31 |
Abbott Lab |
Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
|
DE19522899C1
(de)
*
|
1995-06-23 |
1996-12-19 |
Hexal Pharmaforschung Gmbh |
Verfahren zum kontinuierlichen Ersintern eines Granulats
|
DE69637441T2
(de)
*
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
US7255877B2
(en)
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
DE19705538C1
(de)
*
|
1997-02-14 |
1998-08-27 |
Goedecke Ag |
Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
|
US5891476A
(en)
*
|
1997-12-22 |
1999-04-06 |
Reo; Joe P. |
Tastemasked pharmaceutical system
|
CN1289091C
(zh)
*
|
1998-02-11 |
2006-12-13 |
Rtp药品公司 |
治疗炎症的药物组合物和相关用途
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
CN1245955C
(zh)
|
1998-05-29 |
2006-03-22 |
斯凯伊药品加拿大公司 |
热保护微粒组合物及其最终蒸汽灭菌的方法
|
IL141095A0
(en)
|
1998-08-19 |
2002-02-10 |
Rtp Pharma Inc |
Injectable aqueous dispersions of propofol
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
JP4809533B2
(ja)
|
1998-11-20 |
2011-11-09 |
オバン・エナジー・リミテッド |
分散し得るリン脂質で安定化されたミクロ粒子
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
US8663692B1
(en)
*
|
1999-05-07 |
2014-03-04 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
MXPA02004293A
(es)
|
1999-10-29 |
2002-10-31 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada..
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
AU2001257115B2
(en)
|
2000-04-20 |
2005-01-27 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
CN100518827C
(zh)
|
2000-10-30 |
2009-07-29 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
AU2002219198B2
(en)
*
|
2000-12-27 |
2006-06-29 |
Ares Trading S.A. |
Lipid microparticles by cryogenic micronization
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
DE10300325A1
(de)
|
2003-01-09 |
2004-07-22 |
Hexal Ag |
Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
|
BRPI0407181A
(pt)
|
2003-02-03 |
2006-02-07 |
Novartis Ag |
Formulação farmacêutica
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
AU2007275034A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophilic abuse deterrent delivery system
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
WO2009080275A1
(en)
*
|
2007-12-21 |
2009-07-02 |
Ludwig-Maximilians-Universität |
Extruded rod-shaped devices for controlled release of biological substances to humans and animals
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
AR077420A1
(es)
|
2009-07-22 |
2011-08-24 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
|
EP2456427B1
(en)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
EP2531176B1
(en)
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
ES2486791T3
(es)
|
2010-09-02 |
2014-08-19 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
|
JP5933553B2
(ja)
|
2010-09-02 |
2016-06-15 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
アニオン性ポリマーを含む不正使用抵抗性剤形
|
LT2736495T
(lt)
|
2011-07-29 |
2017-11-10 |
Grünenthal GmbH |
Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
|
RS56527B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
EP2838512B1
(en)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
AU2015266117A1
(en)
|
2014-05-26 |
2016-11-24 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
US11311570B2
(en)
*
|
2014-08-11 |
2022-04-26 |
Perora Gmbh |
Method of inducing satiety
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
EP3492070A1
(en)
*
|
2017-11-30 |
2019-06-05 |
BIT Pharma GmbH |
Process and device for preparing a solid dispersion
|